Satellite Symposia

Host an Educational Program

Satellite Symposia provide your organization with a unique opportunity to host educational programs before or after DDW scientific sessions, often offering CME credit to participants. A limited number of symposia will be permitted so be sure to reserve yours today. Please note that DDW Council policy prohibits Satellite Symposia during scheduled scientific sessions.

There is no application deadline; however, slots are assigned based on receipt of full payment. We can accept applications until all the slots are full. 

Symposia 2023 are available to view on demand through our virtual platform.


Symposium Scheduling

A limited number of satellite symposia will be permitted at DDW 2024.  This number is driven by hotel meeting space availability, which may vary in each city. Please keep in mind DDW hosts over 300+ In-Conjunction With meetings in addition to symposia only at our contracted hotel locations. The DDW Council prohibits symposia during scheduled scientific sessions. Symposia, or any portion of them, including registration and question-and-answer sessions, may only be held prior to 7:45 a.m. or after 6 p.m. during the designated timeslots. This policy will be strictly enforced, and any violations will result in loss of priority points earned for DDW 2024 if the symposium is hosted or supported by a current showcase supporter. If the symposium is not affiliated with a current industry supporter, DDW will determine the appropriate action, which is not limited to expulsion from participating in future DDW events. 

  • Space will be assigned by DDW on a first come, first served basis, based on hotel availability and when full payment is received. Your symposium will not be placed until DDW has received full payment, regardless of your application date.  Meeting space placement will begin in December 2023. You will receive communication once placement has been made. 
  • Symposia can be placed in any of the official DDW hotels based on meeting space availability. Altering your meeting specifications can result in movement of your symposia to another hotel location. Meeting space reservations are not exclusive to symposia.
  • Meeting space locations can be subject to food and beverage minimums, space rental, audio visual and equipment rental fees that is the responsibility of the symposia host. The symposia fee paid to DDW does not include these additional fees.
  • Space assignments are final and may not be switches unless done so by DDW.
Available Dates and Times
  • Symposia dates are May 17–21, 2024. Only morning and evening slots are available. Morning symposia must end by 7:45 a.m., including question-and-answer periods. Evening symposia cannot start before 6 p.m., including the registration process as well as any food and beverage period. The duration of the symposium is up to the sponsoring company to arrange. 
  • Dates and times submitted on the application are just preferences. DDW will confirm your final date and time, once full payment has been received, based on availability. 
  • All confirmed dates and times are final and may not be switched unless done so by DDW. 

Available Dates and Times:

DatesMorning SlotsEvening Slots
Fri, May 17N/ACall for information
Sat, May 1826
Sun, May 1926
Mon, May 2026
Tues, May 212N/A
Fees and What's Included

The fee for one morning slot is $50,000, and the fee for one evening slot is $55,000. Please see the list below for additional information.

Morning symposium$50,000
Evening symposium$55,000
Two morning symposia$75,000
Two evening symposia$85,000
Morning and evening symposia$80,000
Morning symposium (non-exhibitor)$57,500
Evening symposium (non-exhibitor)$62,500
  • DDW will assign appropriate meeting space, day, time and provide the appropriate hotel contacts.
  • DDW will provide one complimentary pre-registrant mailing list for use to promote the symposium. Subsequent lists can be purchased and are discounted 50% from the regular fee. Pre-registration list will be exported from the DDW registration database. DDW is not responsible for list clean up or integrity of this list. List will be supplied by request.
  • DDW will send one combined email blast to attendees about two weeks prior to the convention.
  • DDW will provide two complimentary attendee badges (per symposium) to non-ticketed DDW scientific sessions..  Complimentary attendee name badges are due by Wednesday, April 3, 2024.
  • DDW will list your Symposium on the DDW website, mobile app and online platform prior to the convention. 
  • If you wish to have an online component for your Satellite Symposium, it is your responsibility to coordinate.  Supporters will be responsible for providing the link to the online symposium or recording. DDW will place the link on the online platform and on through Friday, Aug. 30, 2024. Link to your online meeting room, website or recording will be due to DDW by Friday, April 26, 2024. More information will be provided once a contract is submitted.
Marketing Opportunities

For marketing opportunities for Satellite Symposia, please email your industry contact below.




Account Manager

Industry Sales and Operations

[email protected]

DDW Policies


  • DDW reserves the right to review all symposium applications and promotional materials and to reject topics, formats or materials deemed inappropriate.  
  • Program content must be relevant to digestive health or GI practice.  
  • Approval from DDW does not constitute an endorsement of the program or its contents by DDW or its partnering societies. 


Printed and Published Materials 

  • All industry sponsors/supporters must be listed on all printed and published materials.  
  • All printed and published materials must bear the following information: Sponsored by…, Supported by…, and coordinated by…  
  • All advertisements, promotions or invitations for the symposium must bear the following statement: “This program is not affiliated with Digestive Disease Week®.” This statement must appear on the cover/front page of any copy using at least a 12-pt. font size.  
  • The DDW logo and the Digestive Disease Week® (or DDW®) name may not be used in any promotions, advertisements, meeting materials or correspondence related to the program.


Payment Terms 

All DDW Satellite Symposia and Marketing Opportunities will be billed at 100% upon selection and execution of the application and sponsorship contracts.  Payment is due no later than 30 days from the date of order.  Failure to make full payment by this date will result in the item being placed back into inventory for another party to purchase and Satellite Symposia organizers will incur cancellation fees for the Satellite Symposia fee (see below). 


All payments are non-refundable after Saturday, Feb. 3, 2024. 


If an order is placed after Tuesday, Feb. 13, 2024, payment will be due upon reservation.


DDW reserves the right to not fulfill any unpaid Marketing Opportunities.


Space will be assigned only after full payment has been received based on availability at that time.  Meeting space placement will begin in December 2023. You will receive communication once placement has been made.


Cancellation Fee 

Notification of satellite symposium must be in writing. Any supporter canceling a satellite symposium will be charged a fee based on the following schedule:   

  • On or before Tuesday, Feb. 27, 2024: 50% of total fee is due, regardless of whether the slot is re-sold.  
  • After Tuesday, Feb. 27, 2024: 100% of total fee is due, regardless of whether the slot is re-sold. 


Satellite Symposium cancellations will result in automatic cancellation of any marketing opportunities and registered staff secured for the satellite symposium. No refunds will be provided for these other opportunities. 


How many people attend DDW?

Approximately 13,000+ attendees for both in-person and the online platform.

How many people ususally attend a Satellite Symposium, and what is the audience demographic?

DDW does not guarantee attendance. Attendance heavily depends on your topic; however, date and time may have some impact based on conflicting priorities. Attendance is primarily driven by pre-show marketing efforts and tactics deployed by sponsoring organizations. Based on historical data, a.m. symposia can average anywhere between 150-350 attendees, and p.m. symposia average anywhere from 200-500 attendees. DDW does not track audience demographics at symposia. 

Is virtual satellite permitted?

Yes, but we will not coordinate any of the details and you would be required to do so yourself. We also will not provide a virtual platform for it.

Does DDW or any of the sponsoring societies provide CME and/or CE certification?

No. You must provide or independently obtain the CME or CE certification for your activity.

Do society members have to serve as faculty or moderators?


What content involvement/review does DDW have?

DDW is not involved in the content of the actual event, but we must review and approve all copy for invitations and flyers sent to DDW attendees.  

What guidelines does DDW have regarding posting presentations online?

DDW allows partners to post their presentations online if the presentation does not make mention of DDW. Presentations must be hosted by the education partner. DDW will post a link to the education partner’s website on the Satellite Symposia Schedule page for attendees to view post show. Links will be posted until Friday, Aug. 30, 2024.  

Can the sponsor follow up with the attendees by providing enduring materials?

Yes, however it is the sponsor’s responsibility to collect any contact information during the symposium and to acquire all the permissions to contact each attendee. DDW cannot provide attendee contact information. All promotional materials for live streaming presentations or hosting presentations online must follow DDW’s rules and regulations and must be reviewed and approved by DDW prior to release. 

Saturday, May 6, 2023

6 p.m.Test Your Ability to Manage Patients With Irritable Bowel Syndrome With Constipation: A Live Case-Based Challenge
Supported by: Ardelyx
Provided by: Medscape
6–7:30 p.m.
Regency AB, Second Floor
Hyatt Regency McCormick Place
In this live, interactive symposium, expert faculty will present realistic cases to provide context for evidence-based approaches for the diagnosis and management of constipation- predominant irritable bowel syndrome (IBS-C). A series of polling questions will gauge the audiences’ ability to make key clinician decisions regarding diagnosis and treatment selection. Responses will be used to guide the discussion around evidence-based approaches for IBS-C management, including pharmacologic and non-pharmacologic management approaches, and shared decision-making.

Join the livestream here.
S1P Receptor Modulation and JAK Selectivity in Ulcerative Colitis – A Wheel of Knowledge Challenge!
Supported by: Pfizer, Inc.
Provided by: Vindico Medical Education
Registration and dinner: 6–6:30 p.m.
Regency CD
Hyatt Regency Chicago
Join us for this CME dinner symposium to learn about the safety and efficacy of current and emerging therapies and optimal positioning of S1P receptor modulators and selective JAK inhibitors in the shifting UC treatment paradigm. The symposium will feature the A Wheel of Knowledge. During this highly interactive gaming segment, you and your team will partner with a faculty member to compete to win the Wheel of Knowledge Challenge!

Join the livestream here.
6:30 p.m.New Horizons and Expert Insights on the Management of Recurrent Clostridioides difficile Infection
Supported by: Seres Therapeutics, Inc., Aimmune Therapeutics, Ferring Pharmaceuticals Inc.
Provided by: Medscape
6:30–8 p.m.
Regency CDE, Second Floor
Hyatt Regency McCormick Place
Clostridioides difficile causes a serious infection of the lower GI tract, resulting in significant morbidity and sometimes death. Standard antibiotics used to treat toxin-producing C. difficile do not kill the bacterial spores, which leaves patients susceptible to recurrent infections. Novel microbiome-directed biopharmaceutical products are now approved for the prevention of Clostridioides difficile infection (CDI) recurrence and represent a major paradigm shift in the management of CDI. In this hybrid live CME event, clinician experts will review the clinical data on these important new therapies and how they can be incorporated into clinical practice. The audience will have an opportunity to ask questions of the panel in both the live and virtual setting.

Join the livestream here.
Breaking Borders: Optimizing Care for South Asians With IBD in the Mainland and Beyond
Supported by: Takeda Pharmaceuticals U.S.A., Inc., Janssen Pharmaceutical Companies, Lilly
Provided by: Clinical Care Options, LLC
This CME/CE-program is in conjunction with South Asian IBD Alliance.
6:30 p.m.
Prairie Room, Second Floor
Hyatt Regency McCormick Place
IBD is underrecognized and undertreated despite an increasing prevalence in South Asians. Join us at this live, in-person symposium and learn from the experts about the challenges and cultural barriers to IBD care that affect South Asian patients with IBD worldwide.

Sunday, May 7, 2023

6:45 a.m.Enhancing Outcomes for Adults and Children With EoE: Improving Diagnosis and Targeting Type 2 Inflammation
Supported by: Regeneron Pharmaceuticals, Inc and Sanofi
Provided by: Answers in CME
6:45 a.m.
Regency Ballroom C, D, E
Hyatt Regency McCormick Place
Join Dr. Gary W. Falk and Dr. Ikuo Hirano for a discussion of the latest clinical data targeting type two cytokines in the treatment of eosiophilic esophagitis in both adults and children, as well as strategies for integrating approved and emerging biologics into current treatment paradigms.

Join the livestream here.
6 p.m.An Urgent Need in Ulcerative Colitis: Bowel Urgency as a Target for Assessment and Treatment
Supported by: Lilly
Provided by: Med Learning Group
Hyatt Regency McCormick Place
Regency AB
6 p.m.
Join Drs Marla Dubinsky and Parambir Singh Dulai for an interactive discussion focusing on the epidemiology, pathophysiology, diagnosis, and treatment of ulcerative colitis (UC), and aims to result in clinical improvement in the management of UC through an increased understanding of how UC with bowel urgency affects quality of life and clinical outcomes in patients; and an increased ability to apply the latest clinical data on new and emerging agents, and their impact on bowel urgency, to treatment decision making.
6:15 p.m.IBS-C: Evidence-Based and Patient-Centered Management Strategies
Supported by: AbbVie, Inc., Ironwood Pharmaceuticals Inc.
Provided by: HMP Education, an HMP Global Company
6:15 p.m.
Regency Ballroom D
Hyatt Regency Chicago
This complimentary CME/CE event aims to provide invaluable insight into the epidemiology, pathophysiology, diagnosis, and management of Irritable Bowel Syndrome with Constipation (IBS-C). Through interactive lectures, a patient advocate, and Q&A sessions, healthcare professionals will master evidence-based guidance and best practices to elevate their patient care. Join us in person for dinner or virtually on a live-streamed webinar to learn more!
6:30 p.m.Identifying and Managing Complications of Acute-on-Chronic Liver Failure: Variceal Bleeding, Respiratory and Renal Disease in Patients with Cirrhosis
Supported by: Mallinckrodt Pharmaceuticals
Provided by: CiME and Purdue University College of Pharmacy
6:30 p.m. (Buffet served at 6 p.m.)
Regency CDE
Hyatt Regency McCormick Place
The gastroenterology team managing patients with chronic liver disease must be vigilant for extrahepatic complications of cirrhosis/ACLF. ACLF confers high risk of multi-organ failure and mortality as a result of portal hypertension and systemic vasodilation. Extrahepatic complications including renal and respiratory failure are a significant factor in increased mortality risk. This program will discuss ACLF prognosis and complications, to identify these issues and treat effectively; minimizing time to differential diagnosis of HRS/AKI; removing diuretics, monitoring volume and SCr dynamics to proactively treat using evidence-based vasopressor options for patients with HRS/AKI.

Register now:
Join the livestream here.
Navigating the New Treatment Landscape in Inflammatory Bowel Disease
Supported by: AbbVie, Inc.
Provided by: Medscape
6:30–8 p.m.
Prairie Room, Second Floor
Hyatt Regency McCormick Place
The treatment landscape for inflammatory bowel disease (IBD) is changing rapidly. Novel pharmacologic agents with different and unique mechanisms of action that target specific steps in the IBD disease pathway represent significant advances in the treatment of Crohn’s disease and ulcerative colitis. In this live symposium, IBD clinician experts will discuss and differentiate these new and emerging therapies, provide context for their use in clinical practice, and use patient cases to illustrate evolving concepts in risk stratification and treat-to-target approaches. Faculty will also discuss nuances in treatment selection for complex patients and the latest guidance on therapeutic drug monitoring.

Join the livestream here.
Debating Key Concepts in the Management of Nonalcoholic Steatohepatitis
Supported by: Madrigal Pharmaceuticals
Provided by: Medscape
6:30–8 p.m.
Jackson Park
Hyatt Regency McCormick Place
Join the livestream here.

Monday, May 8, 2023

6 p.m.Targeting the Metabolic Mechanisms of NAFLD and NASH: A Fresh Horizon for Improved Outcomes
Supported by: Novo Nordisk, Inc.
Provided by: Institute for Medical and Nursing Education, Inc.
6 p.m.
Regency CDE
Hyatt Regency McCormick Place
Join us for a highly interactive symposium featuring multiple opportunities for audience-expert interaction, including case studies and a question-and-answer session. Learners will hear expert faculty summarize the current state of nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), their relationship with metabolic syndrome and metabolic disorders, and guideline recommendations for management. Next, learners will be given the opportunity to put this information to the test in the “What Would You Do?” segment, where they will be challenged to make clinical decisions for several case questions. The faculty will then review the audience responses and discuss evidence-based practices for treatment decisions. All learners will have the opportunity to participate in exclusive virtual “practice clinics” 3 to 6 months following the symposium. During these small-group sessions that allow direct interaction with expert faculty, learners can discuss changes implemented in their clinics, reflect on successes, and receive advice on overcoming any clinical challenges.

Register now.

Join the livestream here.
Taking Fuel From the IBD Fire: Applying New Evidence on Sphingosine-1-Phosphate Receptor Modulation as an Effective Oral Option for Management of Ulcerative Colitis
Supported by: Bristol Myers Squibb
Provided by: PVI, PeerView Institute for Medical Education
6 p.m.
Prairie Room, Second Floor
Hyatt Regency McCormick Place
This interactive event will offer learners an in-depth look at the complex pathophysiology of IBD, current management paradigms, and challenges in the care of patients with moderately to severely active ulcerative colitis, as well as insight into S1PR modulation as a novel nonbiologic therapeutic option and practical guidance on effectively and safely incorporating this strategy into patient care.

Join the livestream here.

Related Opportunities

Product Theater

Product Theaters are turnkey, 45-minute marketing presentations about your company’s products or services.

ICWs are meetings and events arranged by exhibitors, third party planners, educational institutions or other non-profit organizations during DDW.

In-Conjunction With Meetings

ICWs are meetings and events arranged by exhibitors, third-party planners, educational institutions or other non-profit organizations.

Industry Supporter Prospectus

The prospectus provides details you need to know to reserve your space at DDW 2024.